Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Pediatr Hematol Oncol. 2012 Jul 27;29(6):568–578. doi: 10.3109/08880018.2012.708708

Figure 1. Treatment regimen for patients enrolled on this clinical trial.

Figure 1

In Patient 3, and for subsequent patients on this study, the pre-transplant CY (5 mg/kg/dose) is completely removed. Abbreviations: BM: bone marrow; CSP: cyclosporine; CY: cyclophosphamide; FLU: fludarabine; Gy: Gray; MMF: mycophenolate mofetil; TBI: total body irradiation.